Design
Editorial
Authors
Loading...
This correspondence highlights the ongoing clinical importance of monitoring and mitigating doxorubicin-induced cardiotoxicity, especially with newer combination therapies in breast cancer.
Key points are not available for this paper at this time.
Orhan et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: